Lingfeng Min
Impact in
-
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
-
- Ferroptosis and cancer prognosis 2
- Respiratory Support and Mechanisms 2
- Occupational and environmental lung diseases 2
- Lung Cancer Diagnosis and Treatment 2
- Pleural and Pulmonary Diseases 2
-
- RNA modifications and cancer 3
- Co-authors
- Xingxiang Xu (6 shared papers)Xizhi Zhang (4 shared papers)Chuanli Ren (1 shared paper)Tao Wang (1 shared paper)Changjiang Sun (2 shared papers)Jianqi Yang (2 shared papers)Yong Chen (1 shared paper)Fang Wang (1 shared paper)
In The Last Decade
Lingfeng Min
25 papers receiving 340 citations
Peers
Comparison fields: 5 of 54
- Cancer Research 83
- Bioengineering 20
- Pulmonary and Respiratory Medicine 74
- Obstetrics and Gynecology 17
- Oncology 41
Countries citing papers authored by Lingfeng Min
This map shows the geographic impact of Lingfeng Min's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lingfeng Min with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lingfeng Min more than expected).
Fields of papers citing papers by Lingfeng Min
This network shows the impact of papers produced by Lingfeng Min. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lingfeng Min. The network helps show where Lingfeng Min may publish in the future.
Co-authors
The 25 scholars most cited alongside Lingfeng Min, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 89 | |
| 2 | 2023 | 44 | |
| 3 | 2019 | 35 | |
| 4 | 2012 | 25 | |
| 5 | 2019 | 24 | |
| 6 | 2019 | 23 | |
| 7 | 2021 | 12 | |
| 8 | 2017 | 11 | |
| 9 | 2019 | 11 | |
| 10 | 2022 | 10 | |
| 11 | 2023 | 10 | |
| 12 | 2018 | 8 | |
| 13 | 2024 | 8 | |
| 14 | 2017 | 8 | |
| 15 | 2023 | 5 | |
| 16 | 2023 | 4 | |
| 17 | 2020 | 3 | |
| 18 | 2024 | 3 | |
| 19 | 2020 | 2 | |
| 20 | 2017 | 2 |
About Lingfeng Min
Lingfeng Min is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology, Oncology, Cancer Research and Surgery, having authored 25 papers that have together received 344 indexed citations. Recurring topics across this work include MicroRNA in disease regulation (3 papers), RNA modifications and cancer (3 papers), Ferroptosis and cancer prognosis (2 papers), Respiratory Support and Mechanisms (2 papers), Occupational and environmental lung diseases (2 papers), Lung Cancer Diagnosis and Treatment (2 papers), Esophageal Cancer Research and Treatment (2 papers) and Pleural and Pulmonary Diseases (2 papers). The work is most often cited by research in Cancer Research (83 citations), Bioengineering (20 citations), Pulmonary and Respiratory Medicine (74 citations), Obstetrics and Gynecology (17 citations) and Oncology (41 citations). Lingfeng Min has collaborated with scholars based in China, Sweden and Italy. Frequent co-authors include Xingxiang Xu, Xizhi Zhang, Chuanli Ren, Tao Wang, Changjiang Sun, Jianqi Yang, Yong Chen, Fang Wang, Xinchen Sun and Yong Chen. Their work appears in journals such as BMC Pulmonary Medicine, PLoS ONE, Frontiers in Medicine, Journal of Clinical Oncology and CHEST Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.